Recro Pharma: 2Q Earnings Snapshot
MALVERN, Pa. (AP) _ Recro Pharma Inc. (REPH) on Thursday reported a loss of $2.8 million in its second quarter.
The Malvern, Pennsylvania-based company said it had a loss of 13 cents per share.
The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 36 cents per share.
The specialty pharmaceutical company posted revenue of $31.3 million in the period, which also beat Street forecasts. Four analysts surveyed by Zacks expected $24.1 million.
Recro Pharma shares have climbed 37% since the beginning of the year. The stock has climbed 72% in the last 12 months.